Measuring Treatment Effects in Clinical Trials Using Cardiac MRI
- First Online:
- Cite this article as:
- de Waha, S., Fuernau, G., Eitel, I. et al. Curr Cardiovasc Imaging Rep (2011) 4: 98. doi:10.1007/s12410-011-9069-5
- 52 Views
Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.